The efficacy and safety of prednisone, cyclophosphamide, doxorubicin and carmustine (PCAB) in relapsed/refractory multiple myeloma in the era of novel therapy, including as a bridge to CAR-T therapy
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
Key words
multiple myeloma,relapsed/refractory multiple myeloma,cyclophosphamide,prednisone
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined